Multiple Parties's questions to Recursion Pharmaceuticals Inc (RXRX) leadership • Q2 2025
Question
Multiple analysts inquired about the Bolts two project, questioning if it was the previously mentioned foundational model partnership, why it was open-sourced, and whether Recursion is still developing proprietary models.
Answer
Co-Founder and CEO Chris Gibson confirmed Bolts two was the partnership alluded to at JPMorgan. He explained that Recursion open-sources tools in competitive areas to help commoditize the technology, while keeping truly differentiated platforms like their large-scale phenomics proprietary. He affirmed that Recursion continues to build proprietary models, leveraging architectures like Bolts two on larger, internal datasets for a competitive advantage.